Clinical forecasting is now leveraging innovative informatics capabilities for more precise recruitment and endpoint projections during a study’s crucial…


Megamerger-happy investors bid up AZ shares on speculation that Novartis might try a takeover

Sanofi nabs long-sought FDA approval for daily GLP-1 contender Adlyxin

AstraZeneca, already plagued by Crestor generics, posts street-beating Q2 on diabetes, new cancer meds

No post-Brexit exit for GSK and AstraZeneca, CEOs will say this week as biopharma rumors swirl

Valeant's Relistor a future blockbuster? With AZ in the game, analysts aren't buying it

AZ frustrated with Tagrisso NICE delay, calls for reform

AZ's FDA-rejected diabetes combo grabs first-to-market status in Europe

AstraZeneca's bid to protect Crestor fails as judge refuses to block new generics

AZ's Tagrisso trumps chemo in PhIII on its quest for $3B sales mark

AstraZeneca settles Sandoz patent fight over its top-selling cancer med